McKesson (MCK) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $105.97B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Distribution |
| Country | US | CEO | Brian S. Tyler |
| IPO Date | 1994-11-10 | CAGR | 11.67% |
| Employees | 42,300 | Website | www.mckesson.com |
| Div. Yield | 0.39% | Payout Ratio | 9% |
| Buy Back Yield | 5.23% | Total Yield | 5.62% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $100.24B | P/E | 22.17 | Forward P/E | 17.28 | PEG | -1.31 |
| P/S | 0.25 | P/B | -24.18 | P/CF | 14.95 | P/FCF | 15.24 |
| Sales | $410.98B | Sales 1Y | 8.84% | Sales 3Y | 44.69% | Sales 5Y | 67.6% |
| EPS | $40.82 | EPS 1Y | 49.12% | EPS 3Y | 39.49% | EPS 5Y | -232.19% |
| Sales QoQ | 9.43% | EPS QoQ | -62.44% | Sales QoQ Avg | 2.13% | EPS QoQ Avg | 7.69% |
| Gross Margin | 3.64% | Operating Margin | 1.62% | Profit Margin | 1.12% | ROCE | 37.02% |
| ROA | 5% | ROE | -194% | Altman Z Score | 5.85 | Piotroski Score | 7 |
| Current Ratio | 0.89 | Quick Ratio | 0.52 | Cash Ratio | 0.07 | Op. CF Ratio | -0 |
| Debt/Equity | -2.76 | Debt/Assets | 0.13 | Lt Debt/Equity | -2.38 | Lt Debt/Cap. | 2.01 |
| Intrst Cov. | 43.49 | Inventory Turnover | 15.08 | Asset Turnover | 4.65 | Receivables Turnover | 13.56 |
| Enterprise Value | $100.24B | P/E Ratio | 22.17 |
| Forward P/E | 17.28 | PEG Ratio | -1.31 |
| P/S Ratio | 0.25 | P/B Ratio | -24.18 |
| P/CF Ratio | 14.95 | P/FCF Ratio | 15.24 |
| EPS | $40.82 | EPS Growth 1Y | 49.12% |
| EPS Growth 3Y | 39.49% | EPS Growth 5Y | -232.19% |
| Revenue Growth 1Y | 8.84% | Gross Margin | 0.04% |
| Operating Margin | 0.02% | Profit Margin | 0.01% |
| ROE | -1.94% | ROA | 0.05% |
| ROCE | 0.37% | Current Ratio | 0.89 |
| Quick Ratio | 0.52 | Cash Ratio | 0.07 |
| Debt/Equity | -2.76 | Interest Coverage | 43.49 |
| Altman Z Score | 5.85 | Piotroski Score | 7 |
McKesson (MCK) valuation & financials
McKesson (MCK) has a market capitalization of $105.97B and trades at a price-to-earnings ratio of 22.2. It operates in the Healthcare sector (Medical - Distribution).
McKesson's revenue grew +8.8% over the last year.
McKesson's next earnings report is scheduled for November 4, 2026 after market close; analysts estimate EPS of $10.74. Check the earnings calendar to see all companies reporting this week.
McKesson (MCK) — frequently asked questions
When does McKesson (MCK) report earnings next?
McKesson is expected to report earnings on November 4, 2026 after market close. Analysts estimate EPS of $10.74.
What is McKesson's market cap?
McKesson (MCK) has a market capitalization of $105.97B.
What is MCK's P/E ratio?
McKesson trades at a price-to-earnings ratio of 22.2, with trailing twelve-month EPS of $40.82.
How fast is McKesson growing?
McKesson's revenue grew +8.8% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)